Trials / Completed
CompletedNCT04250194
Navigation Endoscopy to Reach Indeterminate Lung Nodules Versus Trans-Thoracic Needle Aspiration
Navigation Endoscopy to Reach Indeterminate Lung Nodules Versus Trans-Thoracic Needle Aspiration, a Randomized Controlled Study (VERITAS)
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 288 (actual)
- Sponsor
- Vanderbilt-Ingram Cancer Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study will evaluate which procedure is the best for patients referred for biopsy of a lung nodule (growth in the lung) meeting the size and location requirements of the protocol. Two different procedures are available for lung nodule biopsy: 1. a computed tomography guided biopsy ("CT-guided biopsy") which consists of sampling the nodule from the "outside-in", through the chest wall with CT guidance, and 2. navigation bronchoscopy, which is a procedure using technology designed to guide a catheter through the natural airway route (wind-pipe and bronchi) to access the nodule.
Detailed description
Endpoints: Primary: • To evaluate diagnostic accuracy through 12 months of clinical follow-up Secondary: * To evaluate rate of pneumothorax. * To evaluate rate of pneumothorax requiring chest tube placement. * To evaluate clinically significant bleeding (defined by bleeding requiring intervention). * To evaluate need for hospitalization after procedure. * To evaluate duration of the procedure. * To evaluate procedural factors associated with improved yield (type of biopsy, number of biopsies, use of radial ultrasound, presence of a bronchus sign, biopsy site). * To evaluate need for additional nodule biopsy. * To evaluate need for additional procedure for staging. * To evaluate radiation exposure from fluoroscopy-guided bronchoscopy and CT for CT-guided biopsy. * To evaluate need for F-Nav (digital tomosynthesis) during navigation bronchoscopy. * To evaluate diagnostic yield * To evaluate the rate at which the biopsy procedure yields a confident clinical diagnosis (including any added yield from endobronchial ultrasound-guided mediastinal and/or hilar lymph node biopsies or microbiologic studies which yield an explanation for a nodule despite non-diagnostic biopsy specimens).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | CT-Guided Biopsy | Images will be generated by a CT scanner to accurately insert a needle into the lung nodule allowing a sample to be removed for testing |
| DEVICE | Navigation bronchoscopy | A virtual three-dimensional map of the lung will be generated enabling the physician to perform an anatomically precise biopsy |
Timeline
- Start date
- 2020-05-22
- Primary completion
- 2024-06-10
- Completion
- 2024-07-02
- First posted
- 2020-01-31
- Last updated
- 2025-09-29
- Results posted
- 2025-07-14
Locations
7 sites across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT04250194. Inclusion in this directory is not an endorsement.